|
|
 | | | |
- close
- close
- close
- close
Facet Biotech Corp (FACT) |
QUOTE AND NEWS
Marketwire
Apr 5
Comment
REDWOOD CITY, CA -- (Marketwire) -- 04/05/10 -- Facet Biotech Corporation (NASDAQ: FACT) today announced that data for the company's daclizumab development program will be presented at the American Academy of Neurology (AAN) 62nd Annual Meeting
MarketWatch
Mar 10
Comment
MarketWatch's daily rundown of major gainers and decliners in the U.S. stock market.
MarketWatch
Mar 9
Comment
Among the companies whose shares are expected to see active trade in Wednesday’s session are American Eagle, Men’s Wearhouse and Gymboree.
BusinessWeek
Mar 9
Comment
Abbott Laboratories, maker of the arthritis drug Humira, agreed to buy Facet Biotech Corp. for $27 a share in cash, for a net $450 million, adding experimental medicines in cancer and immunology.
Marketwire
Feb 23
Comment
REDWOOD CITY, CA -- (Marketwire) -- 02/23/10 -- Facet Biotech Corporation (NASDAQ: FACT) today reported financial results for the fourth quarter and full year ended December 31, 2009. "In our first full year as an independent company, we made
Marketwire
Feb 11
Comment
REDWOOD CITY, CA -- (Marketwire) -- 02/11/10 -- Facet Biotech Corporation (NASDAQ: FACT) today announced that it will release its financial results for the full year and fourth quarter 2009 following the close of the U.S. financial markets on
Marketwire
Feb 2
Comment
REDWOOD CITY, CA -- (Marketwire) -- 02/02/10 -- Facet Biotech Corporation (NASDAQ: FACT) today announced that the company will participate at the 2010 BIO CEO & Investor Conference in New York on Tuesday, February 9, 2010 at 8:30 a.m., Eastern Time.
MarketWatch
Dec 17
Comment
Among the companies whose shares saw active trading were Allegheny Technologies, Pier 1 Imports and Rite Aid.
Reuters
Dec 16
Comment
Facet Biotech Corp said
on Wednesday it agreed to allow The Baupost Group LLC, a big
investor, to increase its stake in the company to as much as 20
percent, in a bid to fight off a hostile bid from Biogen Idec
Inc .
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
